Syngene International Ltd.

539268

Equity

ISIN INE398R01022 / Valor 28993609

Bombay Stock Exchange Ltd. (Mumbai) (2026-09-04)

INR 395.65-1.22%

Syngene International Ltd.
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Syngene International Ltd. is an India‑based contract research, development and manufacturing organization (CRDMO) that offers end‑to‑end scientific services to pharmaceutical, biotechnology, agrochemical and specialty‑chemical clients worldwide. Operating from research and manufacturing campuses in and around Bengaluru, the company provides discovery and preclinical biology and chemistry, ADME/DMPK and toxicology support, process and analytical development, biologics services (including cell line development and biomanufacturing) and GMP manufacturing of active pharmaceutical ingredients and clinical trial supplies, along with regulatory and quality support. Syngene is publicly listed in India and positions itself as a partner for companies seeking outsourced R&D and scalable manufacturing across the drug development continuum.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-39.7%1Y

-50.2%3Y

-37.2%5Y

Performance

32.7%1Y

29.3%3Y

28.4%5Y

Volatility